×
For best experience we recommend to activate Javascript in your browser.
Recombinant C5AR1 antibody (pSer334)
The Rabbit Monoclonal anti-C5AR1 antibody has been validated for WB, FACS and IF. It is suitable to detect C5AR1 in samples from Human.
Quick Overview for Recombinant C5AR1 antibody (pSer334) (ABIN7517211)
Target
See all C5AR1 Antibodies
C5AR1
(Complement Component 5a Receptor 1 (C5AR1))
Antibody Type
Recombinant Antibody
Reactivity
All reactivities for C5AR1 antibodies
Human
Host
All hosts for C5AR1 antibodies
Rabbit
Clonality
All clonalities for C5AR1 antibodies
Monoclonal
Conjugate
All conjugates for C5AR1 antibodies
This C5AR1 antibody is un-conjugated
Application
All applications for C5AR1 antibodies
Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (IF)
Clone
32-G1
Product Details anti-C5AR1 Antibody
(hide)
Binding Specificity
All epitopes for C5AR1 antibodies
pSer334
Purpose
Rabbit recombinant monoclonal antibody raised against human C5AR1.
Cross-Reactivity
Human
Immunogen
Original antibody is raised against a synthetic C5AR1 C-terminal phosphopeptide that contained phosphoserine instead of serine at position 334 and also at the neighboring phosphorylation sites Ser-332 and Ser-338.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Flow Cytometry,Immunofluorescence,Western Blot,The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
In PBS with 0.02 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C. Aliquot to avoid repeated freezing and thawing.
Target Details for C5AR1
(hide)
Target
C5AR1
(Complement Component 5a Receptor 1 (C5AR1))
Alternative Name
C5AR1
Background
Complement component 5a receptor 1
Gene ID
728
Pathways
Complement System
Recently viewed
(hide)
Chat with us , powered by LiveChat